FOR IMMEDIATE RELEASE
A Host of New Products to be Showcased at 2010
Molecular Medicine Tri-Conference
Needham, MA – January 12, 2010 – Cambridge Healthtech Institute announces twenty-four exhibitors to showcase new products at the 17th Molecular Medicine Tri-Conference, taking place February 3-5, at the Moscone Convention Center, San Francisco, CA. The Molecular Medicine Tri-Conference is the predominant event on the west coast focused on integrating the entire spectrum of drug development.
The Molecular Medicine Tri-Conference has experienced six straight years of attendee growth, while maintaining a high quality audience. This year’s event is on track to be another successful event. Spanning three days, the meeting is built around 6 scientific channels, encompassing 11 conferences, providing attendees more learning opportunities than ever before.
The 2010 event will include for the first time the New Product Pavilion, where 30 companies will showcase their new products to event attendees.
New Products Include:
Asterand; human tissue services
Axxin; Molecular Diagnostics Tools & Services
Chemical Computing Group; molecular operating environment
Epicentre Biotechnologies; Nextera™, DNA Sample Prep Kits
Esoterix Clinical Trials Services; companion diagnostics/biorepository
ExonHit Therapeutics; AclarusDx™ Alzheimer’s test
GeneGo; Eureka!™
GenVault Corporation; GenTegra™ RNA/GenTegra™ DNA
GENOMETRICA; Instrumentation for Molecular Diagnostics
IDBS; The Biomarker Discovery and Validation Solution
Infosys Technologies; Scientific Innovation Solution
Ingenuity Systems; Ingenuity® Answers
Linguamatics; I2E 3.1
Mercodia; Rat/Mouse Proinsulin ELISA
MitoProd; ciRNA® Circular Interfering RNA
NanoInk; nanoscale protein arrays
NanoString Technologies; nCounter Gene Expression Panels
Novartis Molecular Diagnostics; Diagnostic Assays & Molecular Diagnostics Reagents
Optibrium; StarDrop™
Parthys Reverse Informatics Analytic Solutions; thematic database/services
Prestwick Chemical Inc.; New Prestwick Chemical Library
Primax Biosciences; iPorator-96
SCHOTT North America, Inc.; Nexterion® Slide NC
Sigma Aldrich; Stemgent® Reprogramming Lentivirus for iPSC
Thomson Reuters; Prous Science Integrity and Biomarker Center
Transgenomic Inc.; cold PCR
Trans-Hit Biomarkers, International directory of biobanks/Worldwide in-licensing biomarkers opportunities
TriLink BioTechnologies; CleanAmp™ dNTPs
WiCell Research Institute; Cytogenetic Testing Services
Zeptosens; ZeptoVIEW 3 - Reverse Array Protein Profiling Software for ZeptoMARK Booth # 213
About Molecular Medicine Tri-Conference
Molecular Medicine Tri-Conference -- the flagship event of CHI - has built this year's event around 6 scientific channels, encompassing 11 conferences, providing attendees more learning opportunities than ever before. Featured channels include diagnostics, chemistry, informatics, biologics, cancer and executive. We are looking to provide attendees a more in depth experience into each of these six areas of research and development. As the need for better information, new technologies, improved strategies and competitive intelligence becomes ever more acute, this event provides compelling research insight into the future of molecular medicine. In 2010, we expect close to 3,000 attendees, 1200 participating companies, 150 exhibitors, 100 posters, and representatives from over 38 countries. www.Tri-Conference.com
About Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI's portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech's Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.
Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business. www.chicorporate.com
Contact:
Tracey Fielding
Cambridge Healthtech Institute
Ph. 781-972-5429
tfielding@healthtech.com
# # #